Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population-Reference-Cited by-同舟云学术

Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population

Published:2022-01 Issue: Volume:768 Page:136364
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Yuferov Vadim,Butelman Eduardo R.,Randesi Matthew,Ott Jürg,Kreek Mary Jeanne

Publisher

Elsevier BV

Subject

General Neuroscience

Reference51 articles.

1. Stress, dysregulation of drug reward pathways, and the transition to drug dependence;Koob;Am. J. Psychiatry,2007

2. Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain;Wang;Brain Res. Mol. Brain Res.,1999

3. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen;Spangler;Brain Res. Mol. Brain Res.,1993

4. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides;Hurd;Brain Res. Mol. Brain Res.,1992

5. Pharmacotherapy of addictions;Kreek;Nat. Rev. Drug Discov.,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859;Neuroscience Letters;2024-06

2. Polymorphisms of the OPRM1, OPRK1, and DCC Genes and Non-Suicidal Self-Harming in Adults;Neuroscience and Behavioral Physiology;2024-05

3. Endogenous opiates and behavior: 2022;Peptides;2023-11

4. Detecting the OPRK1 rs963549 and rs997917 Polymorphisms by Novel PCR-RFLP Methods and Determining Their Genotype/Allele Frequencies in a Turkish Population;Biology Bulletin;2023-08-10

5. OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder;Environmental Toxicology and Pharmacology;2023-06